Amundi - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
Amundi ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$189,275
-16.0%
6,538
-10.9%
0.00%
Q2 2023$225,203
-20.4%
7,338
-10.9%
0.00%
Q1 2023$282,893
-4.0%
8,238
-11.8%
0.00%
Q4 2022$294,801
-94.8%
9,338
-95.8%
0.00%
-100.0%
Q3 2022$5,628,000
-2.2%
221,838
-0.9%
0.00%
-40.0%
Q2 2022$5,754,000
+26.0%
223,838
+89.8%
0.01%
+66.7%
Q1 2022$4,568,000
+24.0%
117,9380.0%0.00%
+50.0%
Q4 2021$3,684,000117,9380.00%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders